Maharashtra FDA seized Aciloc drugs valued at Rs 2.45 crore. The action followed inspections revealing deceptive labelling and branding changes. The department ordered a complete market recall of the affected Aciloc products. This move prioritizes public health and patient safety by preventing medication confusion. Further legal action will be initiated based on investigation findings.